Home » Genentech¿s Activase Approved For Use In CVAD Application

Genentech¿s Activase Approved For Use In CVAD Application

Sep. 6, 2001

No Comments

Article reprints

Popular Stories

Data needed for Chinese COVID-19 vaccines against Delta variant
BioWorld Asia
The lack of data surrounding the efficacy of Chinese COVID-19 vaccines against the Delta variant has had many questioning them, especially after a recent study...
Data needed for Chinese COVID-19 vaccines against Delta variant
BioWorld
The lack of data surrounding the efficacy of Chinese COVID-19 vaccines against the Delta variant has had many questioning them, especially after a recent study...
Today's news in brief
BioWorld
BioWorld briefs for July 30.
Today's news in brief
BioWorld MedTech
BioWorld MedTech's briefs for July 30.
Aicuris heads for phase III with herpes drug pritelivir
BioWorld
Aicuris Anti-Infective Cures AG is beginning the pivotal phase III part of its trial of pritelivir for herpes simplex virus infection after an encouraging...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe